Skip to main content
An official website of the United States government
Español
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

dexrazoxane hydrochloride

(DEX-ruh-ZOK-sane HY-droh-KLOR-ide)
A drug used to treat severe side effects caused by certain types of anticancer drugs. It is used under the brand names Totect and Zinecard to reduce heart damage in women who are receiving doxorubicin for breast cancer that has spread to other parts of the body. It is also used under the brand name Totect to treat the toxic effects of an anticancer drug that leaks from a vein into surrounding tissue and causes tissue damage. Dexrazoxane hydrochloride is also being studied in the treatment of some types of cancer. It is a type of cardioprotective agent, a type of chemoprotective agent, and a type of topoisomerase inhibitor. Dexrazoxane is the active ingredient of dexrazoxane hydrochloride.
More Information
Search NCI's Dictionary of Cancer Terms